Orin Hirschman 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-10 4:15 pm Sale | 2020-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | Orin Hirschman | 103,423 4.310% | -53,097 (-33.92%) | Filing |